Alpha Teknova, Inc. TKNO

TKNO Company Overview

Alpha Teknova, Inc. is a life sciences company that develops and manufactures critical reagents, media, buffers, and other materials used in the discovery, development, and commercialization of biologics, cell and gene therapies, vaccines, and molecular diagnostics. The company operates within the broader biotechnology tools and bioprocessing industry and primarily serves biotechnology companies, pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), academic institutions, and diagnostic developers. Its revenue is largely driven by custom and catalog reagent manufacturing, including products used in upstream and downstream bioprocessing workflows.

The company was founded in 1996 and is headquartered in Hollister, California. Over time, Teknova evolved from a laboratory reagent supplier into a specialized manufacturer focused on supporting emerging therapeutic modalities such as mRNA-based products and cell and gene therapies. The company’s positioning is tied to its ability to provide customized formulations, rapid production timelines, and manufacturing support for customers operating in regulated and research-intensive environments. Public disclosures, including SEC filings, indicate that Teknova has emphasized flexible manufacturing and scientific collaboration as competitive differentiators.